AGIX Insider Trading Activity and SEC Form 4 Filings
AGIX insider trading summary
No open-market insider purchases or sales of Atherogenics Inc (AGIX) have been reported on SEC Form 4 in the past 12 months.
Latest AGIX insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Feb 4, 2009 | Sam L Barker | Director | Sell | $210 (6,000 @ $0.04) |
| Feb 4, 2009 | Sam L Barker | Director | Sell | $720 (20,000 @ $0.04) |
| Feb 8, 2008 | Vaughn D Bryson | Director | Buy | $32K (50,000 @ $0.64) |
| Jan 25, 2008 | Sam L Barker | Director | Buy | $8K (20,000 @ $0.39) |
| Jan 25, 2008 | Sam L Barker | Director | Buy | $2K (5,000 @ $0.39) |
| Jan 22, 2008 | Vaughn D Bryson | Director | Sell | $1K (3,386 @ $0.39) |
| Dec 28, 2007 | Vaughn D Bryson | Director | Sell | $5K (13,130 @ $0.38) |
| Dec 28, 2007 | Vaughn D Bryson | Director | Sell | $4K (11,603 @ $0.38) |
| Dec 27, 2007 | Vaughn D Bryson | Director | Sell | $19K (48,732 @ $0.40) |
| Dec 26, 2007 | Vaughn D Bryson | Director | Sell | $976 (2,440 @ $0.40) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.